Microneedle structure and method for manufacturing microneedle structure

By using high melting point resin and porous structure in the microneedle structure, the strength and durability of the needle-like part are improved, and the swelling and damage problems of the microneedle when piercing into the skin is solved, achieving more efficient drug supply and safe removal .

CN119053360APending Publication Date: 2024-11-29LINTEC CORP
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202380032405.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-06-30
Filing Date
2023-03-30
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

Existing microneedles are prone to swelling or absorbing when pierced into the skin, making it difficult to remove and may lead to reduced efficiency of the drug supply and defects.

Method used

A microneedle structure has been designed, with a needle-shaped part having a porous structure and a high melting point resin material. The top strength is formed by a specific manufacturing method to achieve a top strength of more than 40mN to prevent damage during piercing, and to improve by optimizing structure and material selection. The strength and durability of the needle-like part.

Benefits of technology

It effectively inhibits the defects and damage of microneedles during use, improves the efficiency and stability of the drug supply, and ensures the safe removal and effective use of microneedles.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119053360A_ABST
    Figure CN119053360A_ABST
Patent Text Reader

Abstract

A microneedle structure (10) according to the present invention is provided with: a needle-shaped part (12) in which a hole is formed; and a base material (11) provided with the needle-shaped part on one surface side. A porous structure is formed in the needle-shaped part (12), and the value of the tip strength of the needle-shaped part (12) is 40 mN or more. The microneedle structure (10) is manufactured by a method for manufacturing the microneedle structure (10). As a result, it is possible to provide: a microneedle structure having a needle-shaped section in which the occurrence of defects or breakage during use is suppressed; and a method for producing the microneedle structure.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a microneedle structure and a method for manufacturing the microneedle structure. Background Art

[0002] In recent years, a technology for supplying a drug into the body and collecting body fluids from the body through a through hole formed in a microneedle has been proposed. For example, a microneedle comprising a microneedle-shaped biocompatible matrix and porous particles provided on the surface or at least a portion of the inside of the biocompatible matrix is ​​known (Patent Document 1).

[0003] Prior art literature

[0004] Patent Literature

[0005] Patent Document 1: Japanese Patent Application Publication No. 2014-094171 Summary of the invention

[0006] Problems to be solved by the invention

[0007] In Patent Document 1, the biocompatible material constituting the microneedle swells or is absorbed by the biological tissue within a few seconds to a few hours when piercing the skin. Therefore, as far as the microneedle is concerned, it is assumed that it will be absorbed in the body. However, from the perspective of safety, it is desired to remove the inserted microneedle as much as possible without leaving it in the skin. Here, for example, when a microneedle containing porous particles as shown in Patent Document 1 is to be removed from the skin after being inserted, there is a problem of microneedle defect. In addition, there is a possibility that damage occurs when piercing the skin, resulting in a decrease in the efficiency of drug supply, etc.

[0008] The present invention has been made in view of such actual circumstances, and an object of the present invention is to provide a microneedle structure having a needle-like portion that is prevented from being chipped or broken during use, and a method for producing the microneedle structure.

[0009] Solutions to the problem

[0010] In order to achieve the above-mentioned purpose, first, the present invention provides a microneedle structure (Invention 1), which comprises a needle-shaped portion with a hole formed inside, and a substrate having the needle-shaped portion on one side, wherein a porous structure is formed in the needle-shaped portion, and the value of the tip strength of the needle-shaped portion measured by the following evaluation method is 40 mN or more (evaluation method: the microneedle structure is placed on a workbench with the needle-shaped portion side facing upward, and observed using a microscope, a needle-shaped body with a sharp tip shape is selected, and the attachment (made of iron, 2 mmφ) of a digital dynamometer is lowered at a descending speed of 5 mm / min according to the position of the needle-shaped portion, and the force applied to the attachment is measured (measurement environment temperature: 23°C, measurement environment relative humidity: 50%), and on the graph outputting the measured force, the maximum value of the force displayed at the position before the force reduction is read at the moment when the force reduction is first observed, or, when the force reduction is not observed until the descending distance of the attachment reaches 100 μm, the force value at the moment when the descending distance of the attachment reaches 100 μm is read, and the value is used as the tip strength of the needle-shaped portion.).

[0011] In the above invention (Invention 1), by setting the value of the tip strength of the needle-like portion to 40 mN or more, it is possible to suppress the needle-like portion from being damaged when the needle-like portion is inserted into the skin.

[0012] In the above invention (Invention 1), it is preferable that the hole portion opens on a side surface of the needle-shaped portion (Invention 2).

[0013] In the above invention (Invention 1), preferably, the needle-shaped portion includes a high melting point resin having a melting point exceeding 130° C., and the substrate includes a layer containing a heat-resistant resin and a liquid can pass therethrough in a thickness direction thereof (Invention 3).

[0014] In the above invention (Invention 3), it is preferred that the high melting point resin is a water-insoluble resin (Invention 4).

[0015] In the above invention (Invention 3), it is preferred that the high melting point resin is a biodegradable resin (Invention 5).

[0016] In the above invention (Invention 3), the high melting point resin is preferably a copolymer of at least one monomer selected from polylactic acid and polyglycolic acid and other monomers (Invention 6).

[0017] In the above invention (Invention 3), it is preferred that the layer containing the heat-resistant resin comprises at least one or more heat-resistant organic polymers selected from polymethyl methacrylate, polystyrene, polyacrylonitrile, polyphenylene ether, polyethylene naphthalate, polyphenylene sulfide, polytetrafluoroethylene, polycarbonate, allyl resin, polyetheretherketone, cellulose acetate resin, polysulfone, polyethersulfone, polyimide and polyamideimide, a copolymer formed by copolymerizing a monomer serving as a raw material of the above heat-resistant organic polymer and any other monomer, or a silicone resin (Invention 7).

[0018] In the above invention (Invention 3), it is preferred that the base material and the needle-shaped portion are directly bonded to each other via a base portion, and the base portion is formed of the same material as that of the needle-shaped portion (Invention 8).

[0019] In the above invention (Invention 1), it is preferred that the needle-shaped portion contains a low melting point resin having a melting point of 130° C. or less (Invention 9).

[0020] In the above invention (Invention 1), it is preferred that the needle-shaped portion contains a high melting point resin and contains a low melting point resin having a melting point of 130° C. or less (Invention 10).

[0021] Second, the present invention provides a method for producing a microneedle structure (Invention 11), wherein the microneedle structure comprises a needle-shaped portion having a hole formed therein, and a substrate having the needle-shaped portion on one side thereof,

[0022] The method includes a step of heating a composition including a high melting point resin having a melting point exceeding 130° C. to form protrusions on the substrate from the composition.

[0023] In the above invention (Invention 11), it is preferred that the high melting point resin is a water-insoluble resin, and the composition is a mixture containing the water-insoluble resin and a water-soluble material.

[0024] This method comprises: after the forming step, a removing step of removing the water-soluble material of the formed protrusions using a solution containing water to form holes in the protrusions (Invention 12).

[0025] Thirdly, the present invention provides a method for producing a microneedle structure (Invention 13), wherein the microneedle structure comprises a needle-shaped portion having a hole formed therein, and a substrate having the needle-shaped portion on one side thereof,

[0026] The method includes a bonding step of heating a composition including a high melting point resin having a melting point exceeding 130° C. to bond the heated composition to the substrate. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] Figure 1(1) A schematic cross-sectional view and (2) a partial enlarged view of the needle-shaped portion of the microneedle structure of the present invention.

[0028] Figure 2 This is a schematic partial cross-sectional view of a test patch using the microneedle structure of the present invention.

[0029] Figure 3 (a) to (c) are explanatory diagrams showing the procedure of a method for producing a microneedle structure according to an embodiment.

[0030] Figure 4 (a) to (c) are explanatory diagrams showing the procedure of the method for producing the microneedle structure according to the embodiment.

[0031] Explanation of symbols

[0032] 10 Microneedle structure

[0033] 11. Substrate

[0034] 12 Needle

[0035] 13 Hole

[0036] 14 Base

[0037] 15 Through hole

[0038] 16 Adhesive layer

[0039] 31. Solid composition

[0040] 32 protrusion

[0041] 33 Mixture DETAILED DESCRIPTION

[0042] Hereinafter, embodiments of the present invention will be described.

[0043] [Microneedle structure]

[0044] exist Figure 1 , a microneedle structure 10 according to an embodiment of the present invention is shown. The microneedle structure 10 has a plurality of needle-like portions 12 separated from each other at given intervals on one side of a substrate 11. A through hole 15 is formed in the substrate 11. In addition, a plurality of holes 13 are respectively formed in the needle-like portion 12. The microneedle structure 10 can be used as an inspection patch that absorbs body fluids from the skin via the holes 13 of the needle-like portion 12 and uses the body fluids obtained via the substrate 11 for inspection; and a drug application patch that applies drugs from the skin to the body via the holes 13 of the substrate 11 and the needle-like portion 12. It should be noted that in the present invention, body fluids include blood, lymph, intercellular lymph, etc.

[0045] (1) Needle-shaped part

[0046] The shape, size, formation spacing, and formation number of the needle-like portion 12 can be appropriately selected according to the purpose of the microneedle as the target. As the shape of the needle-like portion 12, cylindrical, prism-shaped, conical, pyramidal, etc. can be cited, and in the present embodiment, it is a pyramidal shape. The maximum diameter or the maximum size of the cross section of the needle-like portion 12 can be cited as 25 to 1000 μm, the top diameter or the size of the cross section of the top can be cited as 1 to 100 μm, and the height of the needle-like portion 12 can be cited as 50 to 2000 μm. Furthermore, the needle-like portion 12 is provided in multiple columns in one direction of the substrate 11, and multiple columns are formed in each column, arranged in a matrix.

[0047] In the present embodiment, the value of the tip strength of the needle-shaped portion 12 measured by the following evaluation method is 40 mN or more.

[0048] Evaluation method: Place the microneedle structure on a workbench with the needle-shaped side facing upward and observe it under a microscope. Select a needle-shaped body with a sharp tip shape, and lower the attachment of the digital dynamometer (made of iron, 2mmφ) at a descending speed of 5mm / min according to the position of its needle-shaped part. Measure the force applied to the attachment (measurement environment temperature: 23°C, measurement environment relative humidity: 50%). On the graph outputting the measured force, read the maximum force value displayed at the position before the force decreases at the moment when the force decreases for the first time. Alternatively, if no force decrease is observed until the attachment reaches a descending distance of 100μm, read the force value at the moment when the attachment reaches a descending distance of 100μm, and use this value as the tip strength of the needle-shaped part.

[0049] Regarding the details of the method for evaluating the tip strength, for example, a method for evaluating the tip strength using the procedure and apparatus described in the examples described later can be cited. By setting the tip strength of the needle-shaped portion 12 to such a value, it is possible to suppress the needle-shaped portion from being damaged when the needle-shaped portion 12 is inserted into the skin. From such a viewpoint, the tip strength of the needle-shaped portion is preferably 40 to 500 mN, more preferably 60 to 450 mN, further preferably 85 to 400 mN, and further preferably 100 to 350 mN.

[0050] In the present embodiment, in the first embodiment (hereinafter, also referred to as the "first embodiment") of the resin constituting the needle-shaped portion 12, the needle-shaped portion 12 is preferably formed of a high melting point resin. As the high melting point resin, a high melting point resin having a melting point exceeding 130°C is preferred, and a high melting point resin having a melting point of 135 to 240°C, more preferably 140 to 220°C, and most preferably 145 to 200°C is further preferred. High melting point resins are not easy to soften at a temperature near the room temperature at which the microneedle structure 10 is used. Therefore, by making the needle-shaped portion 12 contain a high melting point resin having a melting point exceeding 130°C, sufficient strength can be maintained. As described later, compared with a structure in which the hole portion is opened only at the top of the needle-shaped portion, a structure in which a plurality of hole portions 13 are opened on the side of the needle-shaped portion 12 can increase the speed of absorbing or releasing the fluid from the needle-shaped portion 12, but on the other hand, the needle-shaped portion 12 becomes brittle and the strength is easily reduced. However, in the present embodiment, since the needle-like portion 12 is formed of a composition containing a high melting point resin having a melting point exceeding 130° C., the strength can be improved, and for example, the needle-like portion 12 can be prevented from being damaged when piercing the skin.

[0051] As such a high melting point resin, a water-insoluble high melting point resin is preferably used. By making it water-insoluble, it will not be dissolved by body fluids when applied to organisms, and the shape of the microneedle structure 10 can be maintained during the desired application time. In addition, as described later, a tiny hole portion 13 can be easily formed. In this embodiment, the needle-shaped portion 12 is formed by a water-insoluble material containing a water-insoluble high melting point resin. As water-insoluble high melting point resins other than the biodegradable resin described later, polypropylene, polyvinylidene fluoride, acetal resin, polycarbonate, etc. can be cited.

[0052] The molecular weight of the high melting point resin is usually 5000 to 1000000, preferably 7000 to 500000, and more preferably 9000 to 300000. Within this range, the needle-shaped portion 12 can be preferably formed.

[0053] In addition, as a high melting point resin, a high melting point biodegradable resin is preferred. Here, a biodegradable resin refers to a plastic that is eventually completely decomposed into CO2 and water by the action of microorganisms existing in nature after use. By making it a biodegradable resin, the impact on the living body can be reduced. As such a biodegradable resin, aliphatic polyesters and their derivatives can be preferably used, and specifically, polyglycolic acid (melting point: 218°C), polylactic acid (melting point: 170°C), polyhydroxybutyric acid (melting point: 175°C) and the like can be mentioned. In addition, copolymers formed by two or more monomers selected from glycolic acid, lactic acid and caprolactone can also be mentioned. As such a copolymer, from the viewpoint of making the melting point exceed 130°C, a copolymer with glycolic acid or lactic acid as the main component of the monomer is preferred. As a high melting point biodegradable resin, polyglycolic acid, polylactic acid, or a copolymer of glycolic acid and lactic acid is preferred, and polylactic acid is more preferred.

[0054] In the present embodiment, in the second embodiment (hereinafter, also referred to as the "second embodiment") of the resin constituting the needle-shaped portion 12, the resin constituting the needle-shaped portion 12 may be a low melting point resin. As the low melting point resin, a material that is solid at room temperature and has a melting point of 130°C or less is preferred, and a material with a melting point of less than 130°C is more preferred. A material with a melting point of 40 to 120°C is particularly preferred, and a material with a melting point of 45 to 100°C is most preferred. By making it solid at room temperature, the shape of the needle-shaped portion 12 can be maintained at room temperature. In addition, if the melting point is below 130°C, when the resin is melted to form the needle-shaped portion 12, it is not necessary to heat it at a high temperature, and the cost is low and the workability is excellent. In addition, even if the resin is bonded to the substrate 11 in a molten state, or the resin is heated in a state where the resin and the substrate are bonded, it can be melted at a low temperature, so that the substrate 11 will not be softened, deformed, or burned, and the degree of freedom in the selection of the substrate 11 is high. Furthermore, even when a nonwoven fabric or a resin film made of synthetic fibers with a low heat resistance temperature is used as the substrate 11, it is possible to prevent the substrate 11 from being deteriorated due to softening of the synthetic fibers. From this viewpoint, the proportion of the low melting point resin relative to the total mass of the resin components contained in the needle-shaped portion 12 is preferably 50% by mass or more, more preferably 70% by mass or more.

[0055] The low melting point resin constituting the needle-shaped portion 12 may further be a water-insoluble resin. By making it water-insoluble, it will not be dissolved by body fluids when applied to a biological organism, and the shape of the microneedle structure 10 can be maintained during the desired application time. In addition, as described later, a tiny hole portion 13 can be easily formed. As the water-insoluble resin, polyolefin resins such as polyethylene and α-olefin copolymers, olefin copolymer resins such as ethylene-vinyl acetate copolymer resins, polyurethane elastomers, acrylic copolymer resins such as ethylene-ethyl acrylate copolymers, etc. can be cited.

[0056] In addition, the low melting point resin constituting the needle-shaped portion 12 can be further a biodegradable resin. As such a biodegradable resin, aliphatic polyesters and their derivatives can be preferably used. In addition, homopolymers of at least one monomer selected from glycolic acid, lactic acid and caprolactone, or copolymers formed by two or more monomers can be cited. In addition, polybutylene succinate (melting point: 84-115° C.), aliphatic aromatic copolyesters (melting point: 110-120° C.), etc. can also be used as low melting point biodegradable resins. Specifically, as polybutylene succinate, BioPBS provided by Mitsubishi Chemical Corporation can be used, and as aliphatic aromatic copolyesters, Ecoflex manufactured by BASF can be used.

[0057] In addition, the biodegradable resin may be a resin whose monomer has an acid dissociation constant of 4 or more. By making the acid dissociation constant of the monomer 4 or more, the effect on the organism when the microneedle structure 10 is applied to the organism can be reduced. It should be noted that the acid dissociation constant of the monomer here, when the monomer is a cyclic ester, is the acid dissociation constant of the hydroxycarboxylic acid formed by the ring opening of the cyclic ester. The acid dissociation constant of the monomer is preferably above 4.0, and more preferably above 4.5. In addition, the acid dissociation constant of the monomer is preferably below 25, and more preferably below 15. As such a monomer constituting a biodegradable resin and having an acid dissociation constant of 4 or more, caprolactone can be cited. In the source monomers of the low-melting-point biodegradable resin, the structural unit having an acid dissociation constant of 4 or more of the monomer is preferably 70% by mass or more, more preferably 80% by mass or more, and more preferably 90% by mass or more in all structural units.

[0058] The molecular weight of the resin constituting the needle-shaped portion 12 is usually 5,000 to 300,000, preferably 7,000 to 200,000, and more preferably 8,000 to 150,000.

[0059] Most preferably, as the low melting point resin constituting the needle-shaped portion 12, polycaprolactone or a copolymer of caprolactone and other polymers which is a water-insoluble low melting point resin and a biodegradable resin and has an acid dissociation constant of 4 or more as a monomer can be cited.

[0060] In the second embodiment, the resin constituting the needle-shaped portion 12 is preferably a low melting point resin having a weight average molecular weight of 40,000 or more, that is, a high molecular weight low melting point resin.

[0061] The weight average molecular weight of the high molecular weight low melting point resin is preferably 40000 or more, more preferably 40000 to 200000, and even more preferably 60000 to 150000. Within this range, the tip strength of the needle-shaped portion 12 can be easily increased.

[0062] In the second embodiment, it is also preferable that the needle-shaped portion 12 further contains a filler. By making the needle-shaped portion 12 contain a filler, the mechanical strength of the needle-shaped portion 12 can be further improved. The filler is preferably contained in the resin of the needle-shaped portion 12 in a dispersed state.

[0063] The filler is preferably formed of a resin, preferably formed of one selected from a natural organic polymer or a modified product thereof, and a biodegradable resin. The filler formed of a resin may be a filler containing an inorganic component such as an organic / inorganic hybrid filler in which an inorganic substance is attached to the surface of resin particles, but in consideration of the effect on the organism, it is preferably formed of only a resin and an organic component, and more preferably formed of only a resin. As a natural organic polymer, cellulose can be cited, and as a filler formed of a natural organic polymer or a modified product thereof, cellulose fibers, cellulose acetate spherical microparticles, etc. can be cited.

[0064] As the biodegradable resin, the above-mentioned resins can be used. However, when a biodegradable resin having a low melting point is used as the resin constituting the needle-shaped portion 12, it is preferable to use a biodegradable resin different from the biodegradable resin. As described later, from the viewpoint of further improving the mechanical strength of the filler, a biodegradable resin having a melting point exceeding 130° C. or having no melting point is preferable. Examples of such biodegradable resins include polylactic acid (melting point: 170° C.), polyglycolic acid (melting point: 218° C.), polyhydroxybutyric acid (melting point: 175° C.), cellulose acetate diacetate (melting point: 230-300° C.), etc. It should be noted that biodegradable resins such as cellulose acetate diacetate are also modified products of natural organic polymers.

[0065] From the viewpoint of further improving the mechanical strength of the needle-shaped portion 12, the filler is preferably formed of a resin having a melting point exceeding 130°C or having no melting point. If the resin has a melting point exceeding 130°C, it is not easy to soften at a temperature near the room temperature at which the microneedle structure 10 is used. Therefore, by forming the filler from a resin having a melting point exceeding 130°C, it is easy to obtain sufficient strength of the microneedle structure 10. In addition, in the case where the filler 12 is formed of a resin having a melting point exceeding 130°C, by adding such a resin that is not easily meltable in the form of a filler, when mixed with a low-melting-point resin, a state in which the filler formed of the resin that is not easily meltable is dispersed in the composition is formed, and it is possible to knead and manufacture at a low temperature without melting, and therefore it is preferred. In addition to the above-mentioned biodegradable resins, examples of resins having a melting point exceeding 130°C or having no melting point include polypropylene (melting point: 155°C), polybutylene terephthalate (223°C), polyethylene terephthalate (melting point: 260°C), polytetrafluoroethylene (melting point: 327°C), melamine resin (melting point: none), unmodified cellulose (melting point: none), etc.

[0066] From the same point of view, the filler is also preferably formed of a resin with a glass transition temperature of -10°C or higher. In addition, the filler is preferably formed of a resin with a glass transition temperature of 80°C or lower. By forming the filler from a resin with a glass transition temperature of 80°C or lower, the filler is easily softened during melting even when melted at low temperatures, and is thus easily fused with the low-melting-point resin. As a result, the strength of the needle-shaped portion 12 produced can be easily improved. It should be noted that when the resin contained in the filler is cross-linked, the polymer having a glass transition temperature of -10°C or higher or 80°C or lower is the polymer before cross-linking. As the resin having a glass transition temperature (Tg) of -10°C or higher and 80°C or lower, there can be mentioned: polypropylene (Tg: 0°C), polybutylene terephthalate (Tg: 50°C), polyethylene terephthalate (Tg: 69°C), polymethyl methacrylate (Tg: 60°C), polylactic acid (Tg: 60°C), polyglycolic acid (Tg: 40°C), polyhydroxybutyric acid (Tg: 15°C), etc. Among them, as described above, biodegradable resins are preferred, preferably polylactic acid, polyglycolic acid, polyhydroxybutyric acid, or copolymers of these polymer monomers. The filler is more preferably formed of a resin having a glass transition temperature of 10 to 80°C, and further preferably formed of a resin having a glass transition temperature of 30 to 75°C.

[0067] The filler is preferably contained at 3 to 50% by mass, more preferably 5 to 43% by mass, and further preferably 10 to 35% by mass relative to the mass of the entire needle-shaped portion 12. If it is less than 50% by mass, it is easy to maintain the shape of the needle-shaped portion 12, and the processability during manufacturing is also improved. If it is more than 3% by mass, it is easier to improve the strength. By containing fillers in a content within this range, it is also easy to form a needle-shaped portion 12 with a desired porosity to maintain liquid permeability while improving the strength of the needle-shaped portion 12 based on the filler. In addition, two or more of the above-mentioned fillers may be contained. In this case, it is also preferred to contain the fillers in such a way that the total amount of the fillers is within the above-mentioned content range relative to the resin constituting the needle-shaped portion 12.

[0068] The shape of the filler can be plate-like (sheet-like), fibrous, spherical, irregular, etc., preferably fibrous. By making the shape of the filler fibrous, it is easy to fuse with the molten low-melting point resin, and it is easy to improve the strength of the obtained needle-shaped portion 12, so it is preferred. As fillers with a fibrous shape, metal fiber fillers, carbon fibers, carbon nanofibers, and cellulose fibers can be mentioned. In the case where the filler is in a shape other than fibrous, for example, in the case of a spherical or irregular shape, as described above, by forming the filler from a resin having a glass transition temperature of 80°C or less, the filler can be easily fused with the low-melting point resin. The particle size of the filler is 0.3 to 150 μm, preferably 0.5 to 125 μm, and more preferably 1 to 100 μm. By making the particle size of the filler 0.3 to 150 μm, it is easy to disperse the filler in the composition containing the low-melting point resin, and in addition, the strength of the obtained microneedle structure 10 can be further improved. The particle size of the filler is a seven-point average of values ​​obtained by observing the filler in the microneedle structure 10 with a scanning electron microscope (SEM) and measuring the length of the longest part of the particle. When the filler is fibrous, the particle size refers to the fiber length.

[0069] As described above, in the first embodiment, the needle-shaped portion 12 is formed of a high melting point resin, but the needle-shaped portion 12 may contain a resin other than a high melting point resin. In this case, from the viewpoint of effectively obtaining the effect of improving the strength of the needle-shaped portion 12, the ratio of the high melting point resin contained in the needle-shaped portion 12 to the total mass of the resin components is preferably 30% by mass or more, more preferably 50% by mass or more, and further preferably 70% by mass or more. As the resin other than the high melting point resin contained in the needle-shaped portion 12, a low melting point resin having a melting point of less than 130°C can be cited, and as the low melting point resin, polycaprolactone (melting point: 60°C), polybutylene succinate (melting point: 84-115°C), aliphatic aromatic copolyester (melting point: 110-120°C) and the like can be cited. In addition, as the low melting point resin contained in the needle-shaped portion 12 together with the high melting point resin, a low melting point resin having a melting point of 130°C or less, which is the same as the low melting point resin used in the second embodiment described above, can be used. By making the needle-shaped portion 12 contain a high melting point resin and a low melting point resin, the tip strength of the needle-shaped portion 12 can be improved and the resin can be melted at a low temperature. In this case, the high melting point resin and the low melting point resin may be kneaded, but by using the resin used for the above-mentioned filler as the high melting point resin and mixing the high melting point resin with the low melting point resin in the form of a filler, it is easier to mix the high melting point resin with the low melting point resin at a low temperature.

[0070] A hole portion 13 serving as a flow path for liquid circulation is formed inside the needle-shaped portion 12. One or more hole portions 13 are formed in one needle-shaped portion 12, and the hole portions 13 are open on the surface of the needle-shaped portion 12. In the present embodiment, a porous structure is formed in the needle-shaped portion 12. If the needle-shaped portion 12 is formed in such a manner that at least a part of it becomes a porous structure, body fluids or drug solutions can pass through the hole portions 13 of the porous structure, and therefore, it is not necessary to mechanically form a nanoscale flow path, which is preferred. In addition, body fluids or drug solutions can flow through the entire flow path of the part of the needle-shaped portion 12 where the porous structure is formed, and therefore, the flow rate can be increased compared to the case where a simple connecting hole is formed. On the other hand, in the case where the needle-shaped portion 12 is formed in such a manner that at least a part of it becomes a porous structure, the needle-shaped portion 12 may become a brittle needle-shaped portion. For example, if part or all of the side surface of the needle-shaped portion 12 is not covered with a porous structure, the hole portion 13 is also open on the side surface of the needle-shaped portion 12. In this case, the flow rate of the liquid can be increased compared with the case where only the tip of the needle-like portion 12 is opened. It is considered that when the needle-like portion 12 is formed with a porous structure or the hole portion 13 is opened on the side of the needle-like portion 12, the needle-like portion 12 becomes brittle, but in the present embodiment, since the needle-like portion 12 having the tip strength within the range of a given value is formed, the needle-like portion 12 that does not become brittle and is not easily damaged or broken can be formed.

[0071] The method for forming the porous structure will be described in detail later, but the porous structure may be formed at the same time as the needle-shaped portion 12 is formed, or the protrusion 32 ( Figure 1 . A method of forming a porous structure on the protrusion 32 after the protrusion 32 is described later, which is preferred from the viewpoint of making the hole portion 13 a continuous structure. In the latter case, for example, the protrusion 32 is formed by mixing two or more different materials, and then at least one material is removed to form the hole portion 13, thereby obtaining a porous structure. In the case where the needle-shaped portion 12 contains a filler, the filler can be contained in a state dispersed in the resin of the needle-shaped portion 12 by adopting the method for forming the porous structure. In the present embodiment, for the needle-shaped portion 12, a protrusion 32 formed of a water-insoluble high melting point resin and a water-soluble material is produced in the manufacturing process described later, and the water-soluble material soluble in water is removed in the removal step to form the hole portion 13, and at the same time, the water-insoluble high melting point resin insoluble in water remains to form a porous needle-shaped portion 12.

[0072] In one mode of the present embodiment, the hole portion 13 is a gap formed by removing the water-soluble material from the protrusion 32 formed by a water-insoluble high melting point resin or a low melting point resin and a water-soluble material, and the body fluid and the drug solution pass through the hole portion 13 as a flow path. As shown in the cross section of the needle-shaped portion 12, it is formed by removing a plurality of gaps and connecting them to each other. Through the hole portion 13, a flow path is formed from the surface of the needle-shaped portion 12 to one side of the substrate 11. The size of the opening of the hole portion 13 is determined according to the purpose of the inspection patch using the microneedle structure 10, and from the perspective of making it easy for the liquid to pass, the size of the opening is preferably 0.1 to 50.0 μm, more preferably 0.5 to 25.0 μm, and further preferably 1.0 to 10.0 μm. The water-soluble material and its content are appropriately selected in the manufacturing process in a manner to achieve such an opening diameter.

[0073] It should be noted that in one mode of the present embodiment, for the needle-shaped portion 12, the water-soluble material is removed from the protrusion 32 formed by a water-insoluble high-melting point resin or a low-melting point resin and a water-soluble material to form a porous structure, but this is not limited to this. The needle-shaped portion 12 can also be formed using a high-melting point resin with a porous structure, or a foaming material can be used to form a porous structure while forming the needle-shaped portion 12, or a porous structure can be formed by sintering a particulate composition containing a high-melting point resin.

[0074] In addition, the needle-shaped portion 12 may also have a base 14 provided at least throughout the region where the needle-shaped portion 12 is formed between the needle-shaped portion 12 and one side of the substrate 11. In the present embodiment, the base 14 is provided in a layered manner throughout one side of the substrate 11 as a whole. The base 14 serves as a base for each needle-shaped portion 12 and has a hole 13 similar to each needle-shaped portion 12. The base 14 is formed, for example, with a thickness of 0.1 to 500 μm. By having such a thickness, while improving the strength of the substrate 11, preferred adhesion is obtained between the needle-shaped portion 12, the base 14 and the substrate 11.

[0075] The base 14 is also preferably a porous structure like the needle-shaped portion 12, and it is more preferable to use the same porous structure material as the needle-shaped portion 12. When the base 14 uses a porous structure, a flow path for liquid circulation is formed inside it, so there is no need to mechanically form the hole 13, and the liquid from the needle-shaped portion 12 can pass through the hole 13 of the base 14 and fill the through hole 15, which is preferred. In the present embodiment, the base 14 is formed of the same high melting point resin as the material described for the needle-shaped portion 12, and is formed by the same process, so it can not only be easily made, but also the needle-shaped portion 12 and the substrate 11 can obtain better adhesion through the base 14, which is preferred. In addition, in the present embodiment, by setting the base 14 as a whole over one side of the substrate 11, the base 14 also exists in the state of being attached to the substrate 11 in the part of the substrate 11 where the needle-shaped portion 12 is not formed, so the strength of the microneedle structure 10 is further improved as a whole.

[0076] (2) Base material

[0077] In the case of the first embodiment described above, that is, when the needle-shaped portion 12 contains a high melting point resin, the substrate 11 is preferably formed in a manner that includes a layer containing a heat-resistant resin and a liquid can pass through the layer in the thickness direction. It should be noted that the layer containing the heat-resistant resin only needs to contain the heat-resistant resin to the extent that the heat resistance can be exerted. The content of the heat-resistant resin contained in the layer containing the heat-resistant resin relative to the mass of the entire resin component is preferably 50% by mass or more, more preferably 65% ​​by mass or more, and further preferably 80% by mass or more. As the heat-resistant resin, heat-resistant organic polymers, silicone resins, etc. can be cited. The glass transition temperature of the heat-resistant organic polymer is preferably 80°C or more, more preferably 110°C or more, more preferably 140°C or more, and further preferably 200°C or more. The glass transition temperature of the heat-resistant organic polymer is the temperature of the intersection of the tangent lines before and after the inflection point of the graph obtained by performing TMA (thermomechanical analysis) on a sample of the heat-resistant organic polymer at a heating rate of 5°C / min. By providing the substrate 11 with a layer containing a heat-resistant resin, when the needle-shaped portion 12 is produced in the production process, the substrate 11 is bonded by melting a composition containing a high melting point resin at a temperature above the melting point, or when the needle-shaped portion 12 is formed by melting a composition containing a high melting point resin at a temperature above the melting point, deformation and deterioration of the substrate 11 can be suppressed even if the substrate 11 is heated at the same time. Since the melting point of the high melting point resin is 130° C. or higher, if the glass transition temperature of the heat-resistant organic polymer is 140° C. or higher, the possibility of obtaining such an effect can be further increased.

[0078] In addition, the fact that liquid can pass through in the thickness direction does not mean that the substrate 11 itself is made of a liquid-permeable material, but it is preferably made of a liquid-impermeable material and is configured in a manner that allows liquid to pass through the through-holes 15 formed in the substrate 11 in the thickness direction of the substrate 11. By making the substrate 11 liquid-impermeable, liquid absorption by the substrate 11 can be suppressed, so that the liquid passes only through the through-holes 15 in the substrate 11. Therefore, the body fluid obtained by the needle-shaped portion 12 or the drug solution transported to the needle-shaped portion 12 will not seep into the substrate 11, and the entire amount can be circulated through the through-holes 15. Therefore, when the microneedle structure 10 is used as a test patch, the body fluid can immediately pass through the substrate 11, so that rapid analysis can be achieved. In addition, even when the microneedle structure 10 is used as a drug administration patch, the drug solution will not seep out, and the entire amount of the drug solution can be quickly supplied to the skin.

[0079] It is more preferred that the layer containing a heat-resistant resin of the substrate 11 is formed of a material having high conformability to the skin and having flexibility. From the viewpoint of imparting liquid impermeability to the substrate 11, the layer containing a heat-resistant resin is preferably a resin film containing a heat-resistant resin. As the heat-resistant resin, as described above, heat-resistant organic polymers, silicone resins, etc. can be cited. As the heat-resistant organic polymer, it is preferably at least one selected from polymethyl methacrylate, polystyrene, polyacrylonitrile, polyphenylene ether, polyethylene naphthalate, polyphenylene sulfide, polytetrafluoroethylene, polycarbonate, allyl resin, polyetheretherketone, cellulose acetate resin, polysulfone, polyethersulfone, polyimide, and polyamide-imide. Among the heat-resistant organic polymers, at least one selected from polyethylene naphthalate, polyphenylene sulfide, polytetrafluoroethylene, polycarbonate, allyl resin, polyetheretherketone, cellulose acetate resin, polysulfone, polyethersulfone, polyimide, and polyamideimide is more preferred, at least one selected from polycarbonate, allyl resin, polyetheretherketone, cellulose acetate resin, polysulfone, polyethersulfone, polyimide, and polyamideimide is more preferred, and at least one selected from polyethersulfone, polyimide, and polyamideimide is more preferred. In addition, as the heat-resistant organic polymer, a copolymer formed by copolymerizing the monomers that are the raw materials of these heat-resistant organic polymers and any other monomers can be used. As such a heat-resistant organic polymer, for example, an acrylonitrile-butadiene-styrene copolymer can be cited. Generally speaking, the higher the glass transition temperature of the heat-resistant organic polymer, the higher the heat resistance of the heat-resistant organic polymer. For example, the general glass transition temperature of polyimide is 300° C. or higher.

[0080] In the case of the second embodiment described above, that is, when a low melting point resin having a melting point of 130° C. or less is used as the resin for forming the needle-shaped portion 12, the composition containing the low melting point resin can be processed at a low temperature, thereby preventing the substrate 11 from being exposed to a high temperature. Therefore, as a layer containing a heat-resistant resin, a resin film using a resin such as polybutylene terephthalate, polyethylene terephthalate, polyethylene, polypropylene, ethylene-vinyl acetate copolymer, vinyl chloride, acrylic resin, polyurethane, polylactic acid, etc. can be used instead of a resin film containing a heat-resistant resin as a layer constituting the substrate, and even if a resin film using these resins is used, deformation of the substrate and the like are not likely to occur.

[0081] The substrate 11 may be a single layer or a structure formed by laminating multiple layers. The thickness of the substrate 11 is preferably 3 to 200 μm, more preferably 10 to 140 μm, and further preferably 30 to 115 μm. If the thickness is 3 μm or more, it is easy to maintain the strength of the substrate 11, and if the thickness is 200 μm or less, the followability to the skin is improved and the liquid transportation time can be shortened.

[0082] In addition, an adhesive layer 16 may be provided on the substrate 11. In the present embodiment, an adhesive layer 161 is provided on the surface of the substrate 11 opposite to the surface (one side) on which the needle-shaped portion 12 is formed. By providing this adhesive layer 161, when a tape is stacked on the surface opposite to the one side of the substrate 11 so as to cover an analysis sheet or the like as described later, there is an advantage that the tape can be easily bonded to the substrate 11 or the adhesiveness between the tape and the substrate 11 can be improved. As an adhesive constituting such an adhesive layer 161, a pressure-sensitive adhesive is preferred, and examples thereof include acrylic adhesives, silicone adhesives, rubber adhesives, and the like, and acrylic adhesives are more preferably used.

[0083] In addition, by providing the adhesive layer 162 on the surface of the substrate 11 on which the needle-shaped portion 12 is formed, in the method for producing the microneedle structure described later, the solid composition 31 ( Figure 1 There is no figure in the figure. It will be described later) is bonded to the substrate 11, and the substrate 11 and the solid composition 31 are placed in a mold, and heated and extruded in the forming process, thereby the microneedle structure 10 can be easily obtained. In the case where the substrate 11 is provided with an adhesive layer 162, there is a risk that a gap is generated between the substrate 11 and the needle-shaped portion 12, causing liquid to leak out, or that the adhesive layer hinders the liquid from passing between the substrate 11 and the needle-shaped portion 12. Therefore, it is preferred to set the adhesive layer 162 in a manner that surrounds the area through which the liquid is to pass in the substrate 11, and to set the non-forming area of ​​the adhesive layer 162 in the central part. It should be noted that although the microneedle structure 10 cannot be easily obtained in this way, for example, a first primer layer (not shown) can be provided instead of the adhesive layer 162 for the purpose of improving the adhesion between the needle-shaped portion 12 and the substrate 11. In addition, even if the substrate 11 has an adhesive layer 162, a first primer layer as an intermediate layer can be provided between the substrate 11 and the adhesive layer 162. Examples of the primer layer include acrylic primer layers and polyester primer layers.

[0084] As the acrylic adhesive, an acrylic adhesive containing an acrylic polymer obtained by polymerizing a monomer having an alkyl acrylate as a main component can be used. The acrylic polymer can be a copolymer of an alkyl acrylate and other monomers. As other monomers, acrylates other than alkyl acrylates such as acrylates having a hydroxyl group, acrylates having a carboxyl group, and acrylates having an ether group, and monomers other than acrylates such as vinyl acetate and styrene can be cited.

[0085] The acrylic polymer can be cross-linked by a reaction between a functional group derived from the above-mentioned acrylate having a hydroxyl group, acrylate having a carboxyl group, etc. and a cross-linking agent.

[0086] In addition to the above-mentioned components, the acrylic adhesive may contain a tackifier, a plasticizer, an antistatic agent, a filler, a curing component, etc. As the coating liquid for obtaining the acrylic adhesive, a solvent-based coating liquid or an emulsion-based coating liquid may be used.

[0087] A plurality of through holes 15 are provided on the substrate 11. In the present embodiment, the needle-shaped portion 12 and the base portion 14 are porous structures, so there is no need to align the positions of the through holes 15 and the needle-shaped portion 12, etc. As long as the through holes 15 are properly formed, the liquid can flow, and the microneedle structure 10 can be easily formed. The shape of the through hole 15 provided on the substrate 11 is circular in plan view in the present embodiment, but is not limited thereto, and may also be rectangular, etc. The through hole 15 has an opening diameter that allows the capillary phenomenon to occur, and from the viewpoint of ensuring a sufficient flow rate of the liquid, it is preferably provided in plurality on the substrate 11. As the opening diameter of the through hole 15, for example, when the opening shape of the through hole 15 is circular, its diameter is 2 mm or less, preferably 0.05 to 1 mm, and more preferably 0.1 to 0.8 mm. In the present embodiment, when transporting liquid from the needle-shaped portion 12, the substrate 11 is liquid-impermeable, so the liquid does not seep into the substrate 11, and the liquid is allowed to flow in the thickness direction of the substrate 11 through the through hole 15. Therefore, the transport distance is short, and when it is configured as a detection patch, detection can be performed at a high analysis speed, and when it is configured as a drug administration patch, the drug solution can be administered at an early stage.

[0088] The total area of ​​each through hole 15 (total area) is preferably 0.05 to 15%, more preferably 0.75 to 10%, and even more preferably 1 to 5% relative to the area of ​​the region on the substrate 11 where the through holes 15 are provided. When the total area of ​​the through holes 15 is 15% or less relative to the area of ​​the above region of the substrate 11, it is easy to ensure the rigidity of the substrate 11. In addition, when the total area of ​​the through holes 15 is 0.05% or more relative to the area of ​​the above region of the substrate 11, body fluid can be more effectively obtained through the substrate 11.

[0089] In the case where the microneedle structure 10 is formed with a base 14, by making the base 14 directly bonded to one side of the substrate 11 and the base 14 and the needle-shaped portion 12 are formed integrally, the needle-shaped portion 12 can be provided on the substrate 11 without an adhesive, etc., the hole 13 is well connected, and the liquid can pass easily. Even if the microneedle structure 10 of such a configuration is not provided with an adhesive layer 16 on the substrate 11, the solid composition 31 can be bonded to the substrate 11 by heating in the formation process in the manufacturing method of the microneedle structure described later, or by a bonding method based on similar heating. In this case, the composition containing the high melting point resin must be heated to a temperature at which it can be bonded to the substrate 11, but in the present invention, since the substrate 11 has a layer formed of a heat-resistant resin, deformation and deterioration of the substrate 11 caused by heating can be suppressed. It should be noted that in the present embodiment, the base 14 is provided over the entire surface of the substrate 11, but is not limited to this. It is preferred that the base 14 is formed at least in the region where the needle-shaped portion 12 is formed. Even in the case where the base 14 is directly bonded to one side of the substrate 11, the first primer layer may be provided on the substrate 11 as described above instead of the adhesive layer 16, and the base 14 may be bonded to the substrate 11 via the first primer layer, or via other layers other than the adhesive layer 16 and the first primer layer.

[0090] The microneedle structure 10 thus formed can be used as a test patch or a drug administration patch. Figure 2 The inspection patch 2 shown is provided with an analysis sheet 17 disposed opposite to the needle-shaped portion 12 at a position of the region where the through hole 15 is formed on the covering substrate 11 of the obtained microneedle structure 10, and a tape 18 is laminated in a manner covering the analysis sheet 17. In the case of a drug application patch, a drug application member is disposed in place of the analysis sheet 17 at a position of the region where the through hole 15 is formed on the substrate 11 of the obtained microneedle structure 10 in a manner opposite to the needle-shaped portion 12, and a tape 18 is laminated in a manner covering the drug application member. In such an inspection patch 2 and a drug application patch, the needle-shaped portion 12 has high strength, so it can penetrate the skin without damaging the needle-shaped portion 12, and the constituent material of the needle-shaped portion 12 can be suppressed from remaining in the body, so it is preferred. It should be noted that the tape 18 that fixes the analysis sheet 17 or the drug application member to the substrate 11 may be an adhesive tape provided with an adhesive layer.

[0091] [Method for producing microneedle structure]

[0092] exist Figure 3 , 4, a method for manufacturing a microneedle patch 1 according to an embodiment of the present invention is shown in FIG. In this embodiment, a mixture 33 containing a high melting point resin and a water-soluble material is bonded to a substrate 11 to obtain a solid composition 31 with a substrate (bonding step), and then the solid composition is heated and pressurized to form a protrusion 32 (forming step), and then the water-soluble material is removed from the protrusion 32 (removal step), and the protrusion 32 is used as the needle-shaped portion 12. The following is a detailed description.

[0093] (Bonding process)

[0094] First, the preparation of the substrate 11 and the solid composition 31 is described. First, the high melting point resin and the water-soluble material are heated, melted and mixed, and a mixture 33 as a composition containing the high melting point resin is prepared. In the present embodiment, the high melting point resin is water-insoluble. When preparing the mixture 33, when the resin is melted, in order to reduce the viscosity, it is preferably heated at a temperature higher than 5°C and lower than 80°C higher than the melting point of the high melting point resin, more preferably at a temperature higher than 10°C and lower than 70°C higher than the melting point of the high melting point resin, and further preferably at a temperature higher than 15°C and lower than 60°C higher than the melting point of the high melting point resin. For example, when polylactic acid with a melting point of 170°C is used as the high melting point resin, it is preferably heated at 175 to 250°C, more preferably at 180 to 240°C, and further preferably at 185 to 230°C. It should be noted that it is preferred that the mixture 33 is in a molten state. When emphasis is placed on heating at a lower temperature, the mixture 33 can be softened to the extent that it adheres to the substrate 11. However, in consideration of reducing the manufacturing time, it is preferred to heat at a temperature above the melting point of the high melting point resin at which the water-insoluble material begins to melt as described above.

[0095] As a water-soluble material, a water-soluble material having at least a higher melting point than normal temperature is preferred. The water-soluble material may be an organic substance or an inorganic substance, and examples thereof include sodium chloride, potassium chloride, sodium carbonate, potassium nitrate, alum, sugar, a water-soluble resin, and the like. As a water-soluble resin, a water-soluble thermoplastic resin is preferred, and a thermoplastic resin having a higher melting point than normal temperature is more preferred. As a water-soluble thermoplastic resin, in addition to the biodegradable resin described later, hydroxypropyl cellulose, polyvinyl pyrrolidone, and the like may be cited. Furthermore, in consideration of the impact on the human body, a water-soluble thermoplastic resin is more preferably a biodegradable resin. As such a biodegradable resin, at least one selected from polyalkylene glycols such as polyethylene glycol and polypropylene glycol, polyvinyl alcohol, collagen, and mixtures thereof may be cited, and polyalkylene glycol is particularly preferred. The molecular weight of the polyalkylene glycol is, for example, 200 to 4,000,000, more preferably 600 to 500,000, and particularly preferably 1,000 to 100,000. Among the polyalkylene glycols, polyethylene glycol is preferably used.

[0096] In addition, the water-soluble resin is preferably a water-soluble resin having a melting point of 200°C or less, more preferably 30 to 180°C, and even more preferably 35 to 150°C. By setting the melting point to 150°C or less, it is possible to easily melt the high melting point resin at the heating temperature when melting the high melting point resin. In addition, in order to make the high melting point resin and the water-soluble material easily melt at the same heating temperature when preparing the mixture 33, the difference between the melting point of the high melting point resin and the melting point of the water-soluble material is preferably 40°C or less, more preferably 30°C or less.

[0097] The water-insoluble high melting point resin and the water-soluble material are preferably mixed at a mass ratio of 9:1 to 1:9, more preferably 8:2 to 2:8, and particularly preferably 7:3 to 3:7. By forming the mixture 33 at this ratio, it is easy to form the needle-shaped portion 12 with a desired porosity, thereby achieving both liquid permeability and strength of the needle-shaped portion 12.

[0098] It should be noted that the mixture 33 may contain not only water-insoluble materials and water-soluble materials as nonvolatile solid components but also other materials. For example, in order to further improve the strength of the needle-shaped portion, a water-insoluble material other than resin such as a silica filler may be contained.

[0099] like Figure 3 As shown in (a), the mixture 33 is injected into the solid composition recess 42 formed in the solid composition mold (mold) 41 (filling step). The solid composition recess 42 may be formed in a shape and capacity capable of storing a desired amount of the mixture 33.

[0100] The material of the solid composition mold 41 is not particularly limited, and is preferably made of an organic silicon compound that allows for easy and accurate mold making and easy peeling of the solidified solid composition 31 . In the present embodiment, it is made of polydimethylsiloxane.

[0101] In the state where the mixture 33 is stored in the solid composition recess 42, in order to flatten the surface of the obtained solid composition 31, a solid composition sheet 43 formed of, for example, polydimethylsiloxane (PDMS) is placed on the upper surface of the solid composition recess 42 as a cover. By keeping it at -10 to 3°C for 1 to 60 minutes together with the solid composition mold 41, the melted mixture 33 solidifies and becomes solid, and therefore, it is peeled off from the solid composition mold 41 together with the solid composition sheet 43, and then the solid composition sheet 43 is peeled off. In this way, a Figure 3 (b) is a solid composition 31 shown.

[0102] In addition, a substrate 11 is prepared. In the present embodiment, the substrate 11 has an adhesive layer 162 on the surface of the substrate 11 on which the needle-shaped portion 12 is formed. The adhesive layer 162 may be formed by coating or application, but in the present embodiment, an adhesive tape having an adhesive layer 162 in a given region is used as the substrate 11. Then, a through hole 15 is formed in the substrate 11. The method for forming the through hole 15 is not particularly limited, and the through hole 15 may be formed, for example, by punching or laser perforation.

[0103] Then, if Figure 3 As shown in (c), the solid composition 31 is attached to the adhesive layer 162 of the substrate 11, so that the substrate 11 and the solid composition 31 are integrated. In this way, by having the adhesive layer 162, the solid composition 31 is bonded to the substrate 11 in advance, the substrate 11 and the solid composition 31 are placed in a mold, and heated and pressed in the forming step of heating and pressing described later, thereby easily obtaining the microneedle structure 10. In addition, the substrate 11 and the solid composition 31 are integrated, thereby facilitating operations such as transportation.

[0104] Next, if Figure 4 As shown in (a), a solid composition 31 having a substrate 11 is arranged in a recess 51 of a mold 52 having a recess 51. A recess 53 for forming a protrusion is also provided at the center of the bottom surface of the recess 51. The solid composition 31 is placed on the recess 53 for forming a protrusion. The recess 53 for forming a protrusion is used to form the needle-shaped portion 12, and is formed in a shape and size corresponding to the needle-shaped portion 12. Furthermore, a cover 54 of the mold 52 is provided on the other side (back side) of the substrate 11. The cover 54 is also formed of polydimethylsiloxane.

[0105] (Formation process)

[0106] Next, proceed Figure 4 (b) The forming step is used to form the protrusion 32 of the desired shape, and heating and pressing may be performed at one time, but it is preferably composed of a preliminary step for starting the melting of the solid composition 31 having the substrate 11, and a main step for sufficiently filling the molten solid composition 31 in the recess 51, etc., as in the present embodiment, in order to sufficiently fill the solid composition 31 in the recess 51 of the mold 52.

[0107] First, in the preparatory process and the main process, if Figure 4 As shown in (b), in a state where the solid composition 31 is placed in the recess 51, the substrate 11 and the solid composition 31 are sandwiched by the mold 52 and the cover 54. Furthermore, in this state, the mold 52 and the cover 54 are placed on the lower stage 56, and the upper stage 57 is set above the mold 52 and the cover 54.

[0108] As the heating conditions in the preparatory process and the main process, it is preferred to heat at a temperature higher than 10°C and lower than 110°C than the melting point of the high melting point resin, more preferably at a temperature higher than 17°C and lower than 95°C than the melting point of the high melting point resin, and further preferably at a temperature higher than 25°C and lower than 80°C than the melting point of the high melting point resin. For example, when polylactic acid having a melting point of 170°C is used as the high melting point resin, it is preferably heated at 180 to 280°C, more preferably at 187 to 265°C, and further preferably at 195 to 250°C. In the present embodiment, the solid composition 31 is heated at a temperature at which it can melt. It should be noted that, for the heating of the solid composition 31, only at least one of the lower stage 56 and the upper stage 57 may be heated, or both may be heated. In the main process, heating may be maintained after the preparatory process, or the temperature may be appropriately changed.

[0109] In this state, the mold 52 is squeezed (pressurized) between the upper stage 57 and the lower stage 56. The pressure in this preliminary process is preferably 0.1 to 5.0 MP. By using a pressure in this range, the solid composition 31 can be melted in a short time, and the molten solid composition 31 can be quickly filled into the recess 51, etc. Moreover, by maintaining for 10 seconds to 10 minutes, the solid composition 31 will be in a melted state. It should be noted that the pressurization conditions can be changed in the preliminary process and the main process. For example, in the main process, pressurization can be performed at a higher pressure or for a longer time than in the preliminary process.

[0110] By performing the preliminary step and the main step as in the present embodiment, the solid composition 31 can be fully melted and simultaneously filled into the recess 51 and the projection forming recess 53. In addition, if the obtained needle-shaped portion 12 or base portion 14 has a porous structure, the bonding area of ​​the needle-shaped portion 12 or base portion 14 with respect to the substrate 11 becomes small, which is not favorable for the bonding between them. However, by heating in the forming step while the substrate 11 and the solid composition 31 are bonded, the bonding between the needle-shaped portion 12 or base portion 14 and the substrate 11 can be improved.

[0111] Then, the mold 52 is removed from the lower stage 37, and the molten solid composition 31 is held at -10 to 3°C for 1 to 60 minutes (refrigeration solidification step) to perform cold solidification. Thus, protrusions 32 with high transferability in a shape corresponding to the protrusion-forming recesses 53 are formed.

[0112] (Except process)

[0113] After the bonding step is completed, a removal step is performed in which the solidified material formed by bonding the protrusion 32 and the base material 11 is separated from the mold 52 and then left to stand in a liquid to remove the water-soluble material, thereby forming the needle-shaped portion 12 .

[0114] The cleaning liquid in the removal process includes water. Figure 4 As shown in (c), in this embodiment, the material formed by bonding the protrusion 32 and the substrate 11 is placed in a cleaning solution 58. By placing it in a cleaning solution containing water, the water-soluble material contained in the protrusion 32 and the like that is exposed to the outside or communicated with the exposed part is dissolved, flows out into the water and is removed. It should be noted that the cleaning solution 58 can contain water, for example, it can be a mixed solvent of water and alcohol. Through this removal, a hole portion 13 is formed in the protrusion 32 and the like, and a needle-shaped portion 12 formed by a water-insoluble component containing a high melting point resin is formed. In addition, in addition to the needle-shaped portion 12, the water-soluble material in the molten solid composition 31 attached to one side of the substrate 11 by filling the recess 51 is also removed, and the base 14 is also formed in the form of the same porous structure. The microneedle structure 10 of this embodiment is thus obtained. In this embodiment, the microneedle structure 10 as the first embodiment described above can be obtained.

[0115] (Inspection of manufacturing methods of patches, etc.)

[0116] Although not shown in the figure, the test patch can be manufactured by disposing the analysis sheet 17 at a given position on the back side of the substrate 11 of the obtained microneedle structure 10, and laminating the tape 18 in a manner covering the analysis sheet 17 (setting process). The lamination method can utilize a conventionally known method, for example, after placing the analysis sheet 17 on the back side of the substrate 11, laminating the adhesive tape 18 having an adhesive layer such as a rubber adhesive, an acrylic adhesive, or a silicone adhesive formed on the tape substrate, which is commonly used, thereby manufacturing the test patch. The drug administration patch can also be manufactured by the same method.

[0117] (Variation Example)

[0118] In the present embodiment, as a solid composition 31, a composition containing a water-soluble material and a high melting point resin is described, but the solid composition 31 is not particularly limited, and may be a solid composition containing a low melting point resin, or may be a solid composition containing a filler. In this case, the microneedle structure 10 of the second embodiment described above can be obtained. In the case of using a solid composition 31 as in the present embodiment, the composition does not contain a solvent, so the discoloration and deformation of the substrate 11 can be suppressed, and thus it is preferred. In addition, in the present embodiment, the bonding process can be performed immediately after the filling process and before the mixture 33 is kept at a low temperature. That is, after the mixture 33 is filled in the recess 42, the substrate is contacted with the mixture 33, the mixture 33 is solidified to form a solid composition 31, and the substrate is bonded to the solid composition 31. In this case, the heat resistance of the substrate 11 is also exerted for the residual heat of the filling process.

[0119] In the present embodiment, in order to easily form the hole portion 13 by removing the water-soluble material, the needle-shaped portion 12 is formed using a water-insoluble high melting point resin, but the method for making the hole portion 13 is not particularly limited. For example, in the forming process, a particulate high melting point resin or the like is filled into the mold 52 and sintered at a temperature above the melting point of the high melting point resin, thereby obtaining a microneedle structure having a porous structure consisting of sintered particles and a plurality of gaps formed between the particles. In this case, too, when the forming process and the bonding process are performed simultaneously, the substrate 11 has a layer formed of a heat-resistant resin, thereby being able to suppress deformation and deterioration of the substrate 11.

[0120] In addition, in the present embodiment, the mixture 33 is filled in the recess 1 to form the solid composition 31, but the present invention is not limited thereto. For example, the forming process may also be based on the following method: on the substrate 11, a liquid composition is prepared so that the viscosity is 0.1 to 1000 mPa·s in a state containing a water-soluble material and a high melting point resin in the form of a liquid composition, and a liquid composition is dripped using a dispenser or the like, thereby forming the protrusion 32. Even if the liquid composition 31 containing a high melting point resin is melted at a high temperature to form the protrusion 32, the substrate is indirectly heated, and the heat-resistant substrate 11 will not be deformed / softened, and the operability is good.

[0121] Furthermore, the bonding process can be performed after the forming process. In this case, even when the protrusion 32 before the removal process or the needle-shaped portion 12 after the removal process are bonded to the substrate 11 with heating, the heat-resistant substrate 11 will not deform / soften, and the workability is good.

[0122] Hereinafter, the present invention will be described in more detail with reference to examples.

[0123] [Example]

[0124] (Example 1-1)

[0125] While heating 3 g of polyethylene glycol (PEG) (weight average molecular weight 4000, melting point 40°C) and 7 g of polycaprolactone (PCL) (weight average molecular weight 10000) as water-soluble materials at 110°C, heating and stirring were performed using a stirrer. Then, 0.5 g of ARBOCEL Natural Cellulose Fibers (average fiber length: 45 μm, manufactured by RETTENMAIER JAPAN Co., Ltd., containing 10% by mass of ignition residue at 850°C / 4 hours in addition to cellulose fibers) was added and stirred again. Thus, a mixture 33 was prepared. A mold 42 for a solid composition formed of polydimethylsiloxane was prepared, and a recess 42 with an opening of a square shape with each side of 15 mm×15 mm and a depth of 1.5 mm was formed in the mold 41 for the solid composition. The mixture 33 was injected in a manner that filled the recess 42 of the mold 41 for the solid composition.

[0126] A solid composition sheet 43 formed of polydimethylsiloxane was placed as a cover on the solid composition mold 41 injected with the mixture 33, and the surface of the solid composition 31 was flattened. In this state, the molten mixture 33 was solidified and solidified by keeping it at 3°C ​​for 5 minutes, and separated from the solid composition mold 41, thereby obtaining a solid composition 31. Next, the adhesive layer 16 of the substrate 11, which is an adhesive tape (an adhesive tape in which an acrylic adhesive layer (25 μm thick) is formed on a polyethylene terephthalate (PET) substrate (100 μm thick)), was adhered to one side of the solid composition 31 to bond them. In this way, a solid composition 31 having a substrate 11 was obtained.

[0127] In order to perform the forming step, a mold 52 having protrusion forming recesses 53 is prepared. The mold 52 is made of polydimethylsiloxane, and the protrusion forming recesses 53 are formed on the surface having the recesses 51 as described in detail below.

[0128] ·Protrusion forming recess shape: quadrangular pyramid with a square cross section

[0129] · Length of one side of the largest cross section of the protrusion forming recess: 500 μm

[0130] ・Height of recessed portion for forming protrusion: 900μm

[0131] · Pitch of recessed portions for protrusion formation: 1000 μm

[0132] Number of recesses for forming protrusions: 13 vertical rows, 13 rows, a total of 169

[0133] ·Size of the area where the protrusion forming recess is formed: 15 mm square

[0134] ·Arrangement of recessed portions for forming protrusions: square grid shape

[0135] A mold 52 was placed on the lower stage 56 of a heating press (manufactured by AS ONE Co., Ltd., AH-1T), and a solid composition 31 with a substrate 11 was placed on the mold 52 in a manner facing the recessed portion 51. A 30 mm square sheet of polydimethylsiloxane (lid 54) was overlapped from above, and a preparatory process was performed while heating at 100°C for the lower stage of the heating press and 90°C for the upper stage, and extruding at 2 MPa for 1 minute and 30 seconds. Then, the main process was performed by extruding at 4 MPa for 30 seconds while maintaining the temperature of the heating press and heating. Furthermore, the substrate 11 and the molten composition received by the cover 54 and the mold 52 were stored in a refrigerator at 3°C ​​for 5 minutes to solidify the composition, thereby forming a protrusion 32 and the like. Then, the substrate 11 is peeled off from the mold 52, and the substrate 11 and the formed protrusions 32 are immersed in purified water at 23°C for 24 hours to dissolve and remove the water-soluble material. Then, the substrate 11 and the molded solid composition 31 are left to stand in a drying oven (30°C) for 5 hours to evaporate the water and dry, thereby obtaining the microneedle structure 10.

[0136] (Example 1-2)

[0137] A microneedle structure 10 was obtained in the same manner as in Example 1 except that 2.0 g of ARBOCEL Natural Cellulose Fibers was added as a filler.

[0138] (Example 1-3)

[0139] A microneedle structure 10 was obtained in the same manner as in Example 1 except that 0.5 g of ARBOCEL Ultrafine Cellulose (average particle size: 6-12 μm, manufactured by RETTENMAIER JAPAN CO., LTD.) was added as a filler instead of ARBOCEL Natural Cellulose Fibers.

[0140] (Examples 1-4)

[0141] A microneedle structure 10 was obtained in the same manner as in Example 1 except that 2.0 g of ARBOCEL Ultrafine Cellulose (average particle size: 6-12 μm, manufactured by RETTENMAIER JAPAN CO., LTD.) was added as a filler instead of ARBOCEL Natural Cellulose Fibers.

[0142] (Examples 1-5)

[0143] A microneedle structure 10 was obtained in the same manner as in Example 1 except that 0.5 g of lactic acid polymer (PLA) particles (glass transition temperature: 60° C., irregular shape, average particle size: 53.4 μm) were added as a filler instead of ARBOCEL Natural Cellulose Fibers.

[0144] (Examples 1-6)

[0145] A microneedle structure 10 was obtained in the same manner as in Example 1 except that 0.5 g of TECHPOLYMER SSX (manufactured by Sekisui Chemicals Co., Ltd., spherical cross-linked polymethyl methacrylate (PMMA) microparticles, PMMA glass transition temperature: 100° C., particle size: 1.5 μm) was added as a filler instead of ARBOCEL Natural Cellulose Fibers.

[0146] (Comparative Example 1-1)

[0147] A microneedle structure was obtained in the same manner as in Example 1 except that ARBOCEL Natural Cellulose Fibers was not added as a filler.

[0148] The microneedle structures obtained in Examples 1-1 to 1-6 and Comparative Example 1-1 were subjected to the following microneedle array transferability evaluation and microneedle tip strength evaluation.

[0149] (Evaluation of microneedle array transferability)

[0150] In each embodiment and comparative example, the protrusions were formed by cooling the composition, and after peeling from the mold, before immersing in purified water, the protrusions were observed with an optical microscope (magnification: 50 times and 100 times), and the number of protrusions remaining on the substrate was counted. The ratio of the remaining number to the total number of protrusions in the design was calculated as the transfer rate. The case where the transfer rate was 50% or more and 100% or less was evaluated as "A", and the case where it was 0% or more and less than 50% was evaluated as "B".

[0151] (Microneedle tip strength evaluation)

[0152] The microneedle structure obtained in the embodiment and the comparative example is placed on a workbench with the needle-shaped part facing upward, and observed under a microscope. A needle-shaped body with a sharp tip shape is selected, and the attachment (iron, 2mmφ) of the measuring device (digital dynamometer (manufactured by IMADA Co., Ltd.) is brought close to the needle-shaped part according to the position of the needle-shaped part, and care is taken not to allow the attachment to contact the adjacent needle-shaped part. The vertical position of the attachment is moved to a position where it contacts the tip of the needle-shaped part but does not apply force to the needle-shaped part. After rising 0.1mm from this point, the attachment is lowered at a descending speed of 5mm / min, and the measurement of the force applied to the attachment (measurement range: 1 to 5000mN) is started. At this time, the measurement temperature is 23°C and the relative humidity is 50%. On the graph outputting the measured force, the maximum force value displayed at the position before the force reduction is read at the moment when the force reduction is first observed, or, if the force reduction is not observed until the descending distance of the attachment reaches 100 μm, the force value at the moment when the descending distance of the attachment reaches 100 μm is read, and this value is used as the tip strength of the needle-shaped portion. The case where the tip strength is 60 mN or more is evaluated as "A", the case where the tip strength is less than 60 mN and is 40 mN or more is evaluated as "B", and the case where the tip strength is less than 40 mN is evaluated as "C". It should be noted that in the transferability evaluation, for the examples or comparative examples with a transfer rate of less than 100%, one needle-shaped portion that has not fallen off the substrate and remains is selected and evaluated. In Examples 1-1 to 1-6 and Comparative Example 1-1, a force reduction was observed before the descending distance of the attachment reached 100 μm.

[0153] Table 1 shows the evaluation results.

[0154] [surface

[0155]

[0156] As shown in Table 1, for the evaluation of microneedle tip strength, in Comparative Example 1-1, the microneedle tip strength was less than 40 mN, which was evaluated as C, but Examples 1-1 to 1-6 were all A or B, and the strength was further improved by containing fillers. In Examples 1-1 to 1-6, the transferability of the microneedle array was evaluated as A or B, and for Examples 1-1 to 1-5, since the interface between the resin constituting the needle-shaped portion 12 and the filler had high adhesion, the resin and the filler were well fused, and therefore, the transferability was improved.

[0157] In Examples 2-1, 2-2 and Comparative Example 2-1, the weight average molecular weight (Mw) is the weight average molecular weight converted to a standard substance: polystyrene standard, measured using gel permeation chromatography (GPC) under the following conditions (GPC measurement). The preparation of the sample for GPC measurement is carried out in the following order. First, 1 g of polycaprolactone (PCL) used in the examples and comparative examples and 9 g of tetrahydrofuran (THF, manufactured by Fujifilm and Wako Pure Chemical Industries, Ltd.) are added to a screw tube, shaken to completely dissolve it, and a 10% PCL solution is prepared. Furthermore, 1 ml of the obtained solution and 9 ml of THF are added dropwise to a separately prepared screw tube to prepare a 1% PCL solution. The 1% PCL solution is filtered using a GD / X syringe filter (manufactured by Whatman) and added dropwise to the GPC apparatus.

[0158] (Measurement conditions)

[0159] ·Measurement device: HLC-8320 manufactured by Tosoh Corporation

[0160] ·GPC column (passed in the following order): manufactured by Tosoh Corporation

[0161] TSK gel superH-H

[0162] TSK gel superHM-H

[0163] TSK gel superH2000

[0164] ·Test solvent: tetrahydrofuran

[0165] ·Measurement temperature: 40℃

[0166] (Example 2-1)

[0167] 3 g of polyethylene glycol (PEG) (weight average molecular weight: 4000) and 7 g of granular polycaprolactone (weight average molecular weight 80000) as water-soluble materials were heated and kneaded at 170° C. by LABO-PLASTOMILL 4C150 (Toyo Seiki Seisaku-sho, Ltd.). Thus, a mixture 33 was prepared. A mold 42 for a solid composition formed of polydimethylsiloxane was prepared, and a concave portion 42 having an opening of a square shape with each side of 15 mm×15 mm and a depth of 1.5 mm was formed in the mold 41 for the solid composition. The mixture 33 was injected in a manner that filled the concave portion 42 of the mold 41 for the solid composition.

[0168] A solid composition mold cover (a sheet formed of polydimethylsiloxane) 43 was placed on the solid composition mold 41 to flatten the surface of the solid composition 31. In this state, the molten mixture 33 was solidified and solidified by keeping it at 3°C ​​for 5 minutes, and separated from the solid composition mold 41 to obtain a solid composition 31. Next, the adhesive layer of the substrate 11, which was an adhesive tape (an adhesive tape in which an acrylic adhesive layer (25 μm thick) was formed on a PET substrate (100 μm thick)), was bonded to the solid composition 31. Thus, a solid composition 31 having a substrate 11 was obtained.

[0169] In order to perform the forming step, a mold 52 having protrusion forming recesses 53 is prepared. The mold 52 is made of polydimethylsiloxane, and the protrusion forming recesses 53 are formed on the surface having the recesses 51 as described in detail below.

[0170] ·Protrusion forming recess shape: quadrangular pyramid with a square cross section

[0171] · Length of one side of the largest cross section of the protrusion forming recess: 500 μm

[0172] ・Height of recessed portion for forming protrusion: 900μm

[0173] · Pitch of recessed portions for protrusion formation: 1000 μm

[0174] Number of recesses for forming protrusions: 13 vertical rows, 13 rows, a total of 169

[0175] ·Size of the area where the protrusion forming recess is formed: 15 mm square

[0176] ·Arrangement of recessed portions for forming protrusions: square grid shape

[0177] A mold 52 was placed on the lower stage 56 of a heating press (manufactured by AS ONE Co., Ltd., AH-1T), and a solid composition 31 with a substrate 11 was placed on the mold 52 in a manner facing the recessed portion 51. A 30 mm square sheet (cover 54) made of polydimethylsiloxane was overlapped from above, and a preparatory process was performed while heating at 2 MPa for 3 minutes while setting the heating temperature of the lower stage of the heating press to 140°C and the heating temperature of the upper stage to 140°C. Then, the main process was performed by extruding at 4 MPa for 30 seconds while maintaining the temperature of the heating press and heating. Furthermore, the substrate 11 and the molten composition received by the cover 54 and the mold 52 were kept in a refrigerator at 3°C ​​for 5 minutes to solidify the composition, thereby forming a protrusion 32 and the like. Then, the substrate 11 is peeled off from the mold 52, and the substrate 11 and the formed protrusions 32 are immersed in purified water at 23°C for 24 hours to dissolve and remove the water-soluble material. Then, the substrate 11 and the molded solid composition 31 are left to stand in a drying oven (30°C) for 5 hours to evaporate the water and dry, thereby obtaining the microneedle structure 10.

[0178] (Example 2-2)

[0179] As the resin constituting the needle-shaped portion 12, 7 g of granular polycaprolactone (weight average molecular weight 40,000) having a molecular weight different from that in Example 1 was used and the temperature of the heating step in the formation step was set to 110°C. A microneedle structure 10 was obtained in the same manner as in Example 1.

[0180] (Comparative Example 2-1)

[0181] As the resin constituting the needle-shaped portion, 7 g of granular polycaprolactone (weight average molecular weight 10,000) having a molecular weight different from that in Example 1 was used, and the temperature of the heating process in the forming process was set to 110°C, and the pressurizing time of the preparatory process was set to 1 minute and 30 seconds. Except for this, a microneedle structure was obtained in the same manner as in Example 1.

[0182] The microneedle structures obtained in Examples 2-1 and 2-2 and Comparative Example 2-1 were subjected to the following microneedle array transferability evaluation and microneedle tip strength evaluation.

[0183] (Evaluation of microneedle array transferability)

[0184] In each embodiment and comparative example, the protrusions were formed by cooling the composition, and after peeling from the mold, before immersing in purified water, the protrusions were observed with an optical microscope (magnification: 50 times and 100 times), and the number of protrusions remaining on the substrate was counted. The ratio of the remaining number to the total number of protrusions in the design was calculated as the transfer rate. The case where the transfer rate was 50% or more and 100% or less was evaluated as "A", and the case where it was 0% or more and less than 50% was evaluated as "B".

[0185] (Microneedle tip strength evaluation)

[0186] The microneedle structure obtained in the embodiment and the comparative example is placed on a workbench with the needle-shaped part facing upward, and observed under a microscope. A needle-shaped body with a sharp tip shape is selected, and the attachment (iron, 2mmφ) of the measuring device (digital dynamometer (manufactured by IMADA Co., Ltd.) is brought close to the needle-shaped part according to the position of the needle-shaped part, and care is taken not to allow the attachment to contact the adjacent needle-shaped part. The vertical position of the attachment is moved to a position where it contacts the tip of the needle-shaped part but does not apply force to the needle-shaped part. After rising 0.1mm from this point, the attachment is lowered at a descending speed of 5mm / min, and the measurement of the force applied to the attachment (measurement range: 1 to 5000mN) is started. At this time, the measurement temperature is 23°C and the relative humidity is 50%. On the graph outputting the measured force, the maximum value of the force displayed at the position before the force reduction is read at the moment when the force reduction is first observed, or, if the force reduction is not observed until the attachment reaches a descending distance of 100 μm, the force value at the moment when the attachment reaches a descending distance of 100 μm is read, and this value is used as the tip strength of the needle-shaped portion. The case where the tip strength exceeds 200 mN is evaluated as "A", the case where the tip strength is 100 to 200 mN is evaluated as "B", and the case where the tip strength is less than 100 mN is evaluated as "C". It should be noted that in the transferability evaluation, for the examples or comparative examples with a transfer rate of less than 100%, one needle-shaped portion that has not fallen off the substrate and remains is selected and evaluated. In Examples 2-1 and 2-2, no force reduction was observed until the attachment reached a descending distance of 100 μm. On the other hand, in Comparative Example 2-1, a force reduction was observed before the attachment reached a descending distance of 100 μm.

[0187] Table 2 shows the evaluation results.

[0188] [Table 2]

[0189]

[0190] As shown in Table 2, in Examples 2-1, 2-2 and Comparative Example 2-1, the microneedle array transferability was evaluated as A. On the other hand, as shown in Table 2, for the microneedle tip strength evaluation, in Comparative Example 2-1, the microneedle tip strength was less than 40 mN, and the evaluation was C. It can be seen that when a low-melting-point resin with a high molecular weight (weight average molecular weight of 40,000 or more) is used, the strength of the needle-shaped portion 12 is the highest.

[0191] (Example 3-1)

[0192] 100 parts by weight of polyethylene glycol (molecular weight 4000, melting point 40°C) as a water-soluble material and 100 parts by weight of polylactic acid (melting point 170°C) as a high melting point material were heated to 190°C and stirred with a stirrer to melt and mix to prepare a mixture. A solid composition mold 42 made of polydimethylsiloxane was prepared, and a concave portion 42 having an opening of a square shape with each side of 15 mm×15 mm and a depth of 1.5 mm was formed in the solid composition mold 41. The mixture 33 was injected in such a manner that the concave portion 42 of the solid composition mold 41 was filled.

[0193] Next, a solid composition sheet 43 made of polydimethylsiloxane was placed as a cover on the solid composition mold 41 into which the mixture 33 was injected, and the surface of the solid composition 31 was flattened. In this state, the molten mixture 33 was solidified and solidified by keeping it at 3° C. for 5 minutes, and thus it was separated from the solid composition mold 41 to obtain the solid composition 31.

[0194] Next, the adhesive layer 162 of the substrate 11, which is an adhesive sheet having an adhesive layer 162 of an acrylic adhesive with a thickness of 25 μm provided on a polyimide film (PI, manufactured by DuPont Toray Co., Ltd., product name: Kapton, thickness: 25 μm), was attached to one side of the solid composition 31 to bond them. Thus, the solid composition 31 having the substrate 11 was obtained.

[0195] In order to perform the forming step, a mold 52 having protrusion forming recesses 53 is prepared. The mold 52 is made of polydimethylsiloxane, and the protrusion forming recesses 53 are formed on the surface having the recesses 51 as described in detail below.

[0196] ·Protrusion forming recess shape: quadrangular pyramid with a square cross section

[0197] · Length of one side of the largest cross section of the protrusion forming recess: 500 μm

[0198] ・Height of recessed portion for forming protrusion: 900μm

[0199] · Pitch of recessed portions for protrusion formation: 1000 μm

[0200] Number of recesses for forming protrusions: 13 vertical rows, 13 rows, a total of 169

[0201] ·Size of the area where the protrusion forming recess is formed: 15 mm square

[0202] ·Arrangement of recessed portions for forming protrusions: square grid shape

[0203] A mold 52 is placed on the lower stage 56 of a heating press (manufactured by AS ONE Co., Ltd., AH-1T), and a solid composition 31 with a substrate is placed on the mold 52 in a manner facing the recess 51. A 30 mm square sheet of polydimethylsiloxane (cover 54) is overlapped from above, and a preparatory process is performed while heating only the lower stage of the heating press at a set heating temperature of 230°C and extruding at 2MPa for 3 minutes. Then, similarly, only the lower stage of the heating press is heated at 230°C, and in this state, it is extruded at 4MPa for 30 seconds to perform the main process. Further, the substrate 11 and the molten composition received by the cover 54 and the mold 52 are stored in a refrigerator at 3°C ​​for 5 minutes to solidify the composition, forming a protrusion 32, etc. Then, the substrate 11 is peeled off from the mold 52, and the substrate 11 and the composition are immersed in purified water at 23°C for 24 hours to dissolve and remove the water-soluble material. Then, the substrate 11 and the formed solid composition 31 were left to stand for 24 hours in an environment of 23° C. and a relative humidity of 50% to evaporate the water and dry the composition, thereby obtaining the microneedle structure 10 .

[0204] (Reference Example 3-1)

[0205] A microneedle structure was produced in the same manner as in Example 1 except that a PSA sheet having a 25 μm thick PSA layer formed of an acrylic PSA on a polyethylene terephthalate (PET) film was used instead of the PSA sheet of Example 1.

[0206] (Comparative Example 3-1)

[0207] In this comparative example, polycaprolactone (melting point 60° C.) as a low melting point resin was used instead of polylactic acid as a high melting point resin in Example 1 to form the needle-shaped portion, and an adhesive sheet having an adhesive layer of 25 μm thick made of an acrylic adhesive on a polyethylene terephthalate (PET) film was used instead of the adhesive sheet of Example 1. In addition, a microneedle structure was produced in the same manner as in Example 1 except that the heating temperature in the bonding step and the forming step was changed as described below.

[0208] Heating temperature during preparation of the mixture in the bonding process: 100°C

[0209] · Lower stage temperature, pressure and time in the preparatory process of the forming process: 110°C, 2MPa, 3 minutes

[0210] The lower stage temperature, pressure and time of the main process in the forming process: 110°C, 4MPa, 30 seconds

[0211] The microneedle structures obtained in Example 1 and Comparative Examples 1 and 2 were subjected to the following evaluations of microneedle array transferability, microneedle tip strength, and substrate deformation.

[0212] (Evaluation of microneedle array transferability)

[0213] In each embodiment and comparative example, the protrusions were formed by cooling the composition, and after peeling from the mold, before immersing in purified water, the protrusions were observed with an optical microscope (magnification: 50 times and 100 times), and the number of protrusions remaining on the substrate was counted. The ratio of the remaining number to the total number of protrusions in the design was calculated as the transfer rate. The case where the transfer rate was 50% or more and 100% or less was evaluated as "A", and the case where it was 0% or more and less than 50% was evaluated as "B".

[0214] (Microneedle tip strength evaluation)

[0215] The microneedle structures of the embodiments and comparative examples were placed on a workbench with the needle-shaped part facing upwards, and observed under a microscope. A needle-shaped body with a sharp tip was selected, and the attachment (iron, 2mmφ) of the measuring device (digital dynamometer (manufactured by IMADA Co., Ltd.) was brought close to the needle-shaped part according to the position of the needle-shaped part, and care was taken not to allow the attachment to contact the adjacent needle-shaped part. The attachment was moved up and down to a position where it touched the tip of the needle-shaped part but did not apply force to the needle-shaped part. After rising 0.1mm from this position, the attachment was lowered at a descending speed of 5mm / min, and the force applied to the attachment (measurement range: 1 to 5000mN) was measured. At this time, the measurement temperature was 23°C and the relative humidity was 50%. On the graph outputting the measured force, the maximum value of the force displayed at the position before the force reduction is read at the moment when the force reduction is first observed, or, if the force reduction is not observed until the attachment reaches a descending distance of 100 μm, the force value at the moment when the attachment reaches a descending distance of 100 μm is read, and this value is used as the tip strength of the needle-shaped portion. The case where the tip strength is 40 mN or more is evaluated as "A", and the case where it is less than 40 mN is evaluated as "B". It should be noted that in the transferability evaluation, for the examples or comparative examples with a transfer rate of less than 100%, one needle-shaped portion that has not fallen off the substrate and remains is selected and evaluated.

[0216] (Evaluation of deformation of base material)

[0217] The shape of the substrate of the obtained microneedle structure was visually observed, and the case where there was no shrinkage, melting, bending, or discoloration of the substrate was designated as "A", and the case where there was at least one of shrinkage, melting, bending, or discoloration of the substrate was designated as "B".

[0218] Table 3 shows the evaluation results.

[0219] [Table 3]

[0220]

[0221] As shown in Table 3, in Example 3-1, the tip strength of the needle-shaped portion was greater than 40 mN, and the deformation of the substrate was also evaluated as A, but in Reference Example 3-1, the deformation of the substrate was evaluated as B, and the microneedle structure of Comparative Example 3-1 failed to obtain a tip strength of the needle-shaped portion greater than 40 mN.

[0222] Industrial Applicability

[0223] The microneedle structure of the present invention can be used as a test patch by, for example, placing an analysis sheet on the back side and laminating the sheet with a tape.

Claims

1. A microneedle structure comprising: A needle-shaped portion having a hole formed therein, and A substrate having the needle-shaped portion on one side, in, A porous structure is formed in the needle-shaped portion, The tip strength of the needle-shaped portion measured by the following evaluation method is 40 mN or more, Evaluation method: Place the microneedle structure on a workbench with the needle-shaped side facing upward and observe it under a microscope. Select a needle-shaped body with a sharp tip shape, and lower the attachment of the digital dynamometer (made of iron, 2mmφ) at a descending speed of 5mm / min according to the position of its needle-shaped part. Measure the force applied to the attachment (measurement environment temperature: 23°C, measurement environment relative humidity: 50%). On the graph outputting the measured force, read the maximum force value displayed at the position before the force reduction when the force reduction is first observed. Alternatively, if no force reduction is observed until the descending distance of the attachment reaches 100μm, read the force value when the descending distance of the attachment reaches 100μm, and use this value as the tip strength of the needle-shaped part.

2. The microneedle structure according to claim 1, wherein The hole portion opens on a side surface of the needle-shaped portion.

3. The microneedle structure according to claim 1, wherein The needle-shaped portion includes a high melting point resin having a melting point exceeding 130° C., The substrate includes a layer containing a resin having heat resistance, and a liquid can pass through the layer in a thickness direction thereof.

4. The microneedle structure according to claim 3, wherein: The high melting point resin is a water-insoluble resin.

5. The microneedle structure according to claim 3, wherein The high melting point resin is a biodegradable resin.

6. The microneedle structure according to claim 3, wherein The high melting point resin is a copolymer of at least one monomer selected from polylactic acid and polyglycolic acid and other monomers.

7. The microneedle structure according to claim 3, wherein: The layer containing the heat-resistant resin includes at least one heat-resistant organic polymer selected from polymethyl methacrylate, polystyrene, polyacrylonitrile, polyphenylene ether, polyethylene naphthalate, polyphenylene sulfide, polytetrafluoroethylene, polycarbonate, allyl resin, polyetheretherketone, cellulose acetate resin, polysulfone, polyethersulfone, polyimide and polyamideimide, a copolymer formed by copolymerizing a monomer serving as a raw material of the heat-resistant organic polymer and any other monomer, or a silicone resin.

8. The microneedle structure according to claim 3, wherein The base material and the needle-shaped portion are directly bonded together via a base portion, and the base portion is formed of the same material as the needle-shaped portion.

9. The microneedle structure according to claim 1, wherein The needle-shaped portion includes a low melting point resin having a melting point of 130° C. or less.

10. The microneedle structure according to claim 1, wherein The needle-shaped portion includes a high melting point resin and a low melting point resin having a melting point of 130° C. or less.

11. A method for manufacturing a microneedle structure, the microneedle structure comprising: A needle-shaped portion having a hole formed therein, and A substrate having the needle-shaped portion on one side, The method includes: A step of heating a composition including a high melting point resin having a melting point exceeding 130° C. to form protrusions on the substrate from the composition.

12. The method for producing a microneedle structure according to claim 11, wherein: The high melting point resin is a water-insoluble resin, The composition is a mixture containing the water-insoluble resin and a water-soluble material. The method includes a removing step of removing the water-soluble material of the formed protrusions using a solution containing water after the forming step, thereby forming holes in the protrusions.

13. A method for manufacturing a microneedle structure, the microneedle structure comprising: A needle-shaped portion having a hole formed therein, and A substrate having the needle-shaped portion on one side, The method includes: A bonding step of heating a composition including a high melting point resin having a melting point exceeding 130° C. to bond the heated composition to the substrate.

Citation Information

Patent Citations

  • Microneedle and microneedle array

    JP2014094171A